Targets for protection and mitigation of radiation injury.

Acute radiation syndrome (ARS) Fibrosis Inflammation Mitigation Mitochondria Normal tissue injury Pneumonitis ROS Radiation Redox

Journal

Cellular and molecular life sciences : CMLS
ISSN: 1420-9071
Titre abrégé: Cell Mol Life Sci
Pays: Switzerland
ID NLM: 9705402

Informations de publication

Date de publication:
Aug 2020
Historique:
received: 04 11 2019
accepted: 07 02 2020
revised: 04 02 2020
pubmed: 20 2 2020
medline: 8 8 2020
entrez: 20 2 2020
Statut: ppublish

Résumé

Protection of normal tissues against toxic effects of ionizing radiation is a critical issue in clinical and environmental radiobiology. Investigations in recent decades have suggested potential targets that are involved in the protection against radiation-induced damages to normal tissues and can be proposed for mitigation of radiation injury. Emerging evidences have been shown to be in contrast to an old dogma in radiation biology; a major amount of reactive oxygen species (ROS) production and cell toxicity occur during some hours to years after exposure to ionizing radiation. This can be attributed to upregulation of inflammatory and fibrosis mediators, epigenetic changes and disruption of the normal metabolism of oxygen. In the current review, we explain the cellular and molecular changes following exposure of normal tissues to ionizing radiation. Furthermore, we review potential targets that can be proposed for protection and mitigation of radiation toxicity.

Identifiants

pubmed: 32072238
doi: 10.1007/s00018-020-03479-x
pii: 10.1007/s00018-020-03479-x
doi:

Substances chimiques

Reactive Oxygen Species 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

3129-3159

Auteurs

Ehsan Khodamoradi (E)

Radiology and Nuclear Medicine Department, School of Paramedical Sciences, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Mojtaba Hoseini-Ghahfarokhi (M)

Radiology and Nuclear Medicine Department, School of Paramedical Sciences, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Peyman Amini (P)

Department of Radiology, Faculty of Paramedical, Tehran University of Medical Sciences, Tehran, Iran.

Elahe Motevaseli (E)

Department of Molecular Medicine, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.

Dheyauldeen Shabeeb (D)

Department of Physiology, College of Medicine, University of Misan, Misan, Iraq.
Misan Radiotherapy Center, Misan, Iraq.

Ahmed Eleojo Musa (AE)

Department of Medical Physics, Tehran University of Medical Sciences (International Campus), Tehran, Iran.

Masoud Najafi (M)

Radiology and Nuclear Medicine Department, School of Paramedical Sciences, Kermanshah University of Medical Sciences, Kermanshah, Iran. najafi_ma@yahoo.com.

Bagher Farhood (B)

Department of Medical Physics and Radiology, Faculty of Paramedical Sciences, Kashan University of Medical Sciences, Kashan, Iran. bffarhood@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH